SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstraße 12, 72072 Tübingen
Phone: +49 7071 9169–0 | Contact: Dr. Cornelius Maas · tuebingen@shs-capital.eu
www.shs-capital.eu
Phone: +49 7071 9169–0 | Contact: Dr. Cornelius Maas · tuebingen@shs-capital.eu
www.shs-capital.eu
Profile
Since its establishment in 1993, SHS has been investing in innovative
companies in the life science and medical technology sectors. With our investments, we help shape European champions in their respective healthcare segments or support them in their further expansion.
Services
In addition to capital, we provide our networks and expertise in the areas of approval and reimbursement in the USA and China, marketing/sales, staffing and exit.
Participation
Type of participation
Majorities or minorities, equity & financial instruments similar to equityFunding Stages
Growth capital & Mittelstand/mid tier: opening up new markets (e.g. USA, China), succession planning, financing scaling and product expansionMinimum investment
Transaction value: up to € 150 million (together with co-investors or LPs), equity tickets SHS up to € 50 million.Investments
AMW, CAM Bioceramics, Develco Pharma, Essert Robotics, Novo Klinik-Service, Mesi Medical, numares, Simulands and Selfapy. Further Investments can be found on our homepage.Capital Managed
Ca. € 500 million* (*We calculate the value as the sum of the fund volumes of all active SHS funds.)Company
Management
Sasa Alilovic · Hubertus Leonhardt · Uwe Steinbacher · Manfred Ulmer-WeberFoundation
1993Team size
19Subsidiaries